TGFB1 and cancer: Of particular note, therefore, monotherapy targeting TGF-β ligand–receptor interaction usually reveals suboptimal and highly variable therapeutic effects, suggesting that the biological functions of TGF-β signaling and the outcome of TGF-β targeting cancer therapies may be largely context-dependent29.